Alchemab Therapeutics vs Genesis Therapeutics
Which Drug Discovery AI tool is better in 2026?
Alchemab Therapeutics
UK biotech using machine learning to mine patient-derived immune responses for protective
Genesis Therapeutics
AI drug-discovery company building generative and predictive models to design small-molecule
Side-by-side
Genesis Therapeutics is the more established option (raised $344M); pricing is comparable on both sides.
| Metric | Alchemab Therapeutics | Genesis Therapeutics |
|---|---|---|
| Taglinei | UK biotech using machine learning to mine patient-derived immune responses for protective | AI drug-discovery company building generative and predictive models to design small-molecule |
| Foundedi | — | — |
| HQi | — | — |
| Employeesi | 11-50 | 11-50 |
| Neuron scorei | 66 | 72🏆 |
| Total fundingi | $32M | $344M🏆 |
| Latest roundi | Series A | Strategic equity investment · May 2026 |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✓ | ✓ |
| Free triali | ✓ | ✓ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Free | Free |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Alchemab Therapeutics and Genesis Therapeutics.
| Capability | Alchemab Therapeutics | Genesis Therapeutics |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✓ | ✓ |
| Free trial | ✓ | ✓ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Alchemab Therapeutics
- Strong in Drug Discovery
🔵 Strengths of Genesis Therapeutics
- Has raised more capital ($344M vs $32M)
- Higher Neuron score (72 vs 66)
Which should you choose?
Choose Genesis Therapeutics if price matters most — it starts at Free, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Genesis Therapeutics if you want the most established option — it has raised $344M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Alchemab Therapeutics vs Genesis Therapeutics — which is better?
It depends on your priority. Alchemab Therapeutics is the leaner option; Genesis Therapeutics has broader feature depth. See the side-by-side table above.
Is Alchemab Therapeutics cheaper than Genesis Therapeutics?
No — Genesis Therapeutics's cheapest paid plan is Free, while Alchemab Therapeutics's is Free.
Do Alchemab Therapeutics and Genesis Therapeutics offer free plans?
Alchemab Therapeutics: Yes, has a free plan. Genesis Therapeutics: Yes, has a free plan.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.